SC
TCRT icon

Sculptor Capital’s Alaunos Therapeutics TCRT Stock Holding History

Sculptor Capital’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-35
Closed -$25K – 293
2019
Q4 		$25K Hold
35
– – ﹤0.01% 280
2019
Q3 		$23K Sell
35
-240
-87% -$190K ﹤0.01% 292
2019
Q2 		$241K Sell
275
-1,430
-84% -$983K ﹤0.01% 258
2019
Q1 		$985K Buy
1,705
+240
+16% +$100K 0.01% 166
2018
Q4 		$411K Buy
+1,465
New +$579K ﹤0.01% 192
2017
Q2 		– Sell
-565
Closed -$538K – 390
2017
Q1 		$538K Buy
565
+184
+48% +$171K ﹤0.01% 259
2016
Q4 		$306K Hold
381
– – ﹤0.01% 290
2016
Q3 		$322K Buy
+381
New +$306K ﹤0.01% 274

Other funds holding TCRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sculptor Capital's TCRT Position: Q1 2020 in Review

Sculptor Capital sold out of Alaunos Therapeutics (TCRT) in Q1 2020, closing a stake of 35 shares — an estimated $25K sold.

Sculptor Capital first reported a position in TCRT in Q3 2016 and held it in 8 quarters. The position peaked at $985K in Q1 2019. 146 funds tracked by Wall St. Rank hold TCRT as of Q1 2020.

  • Sculptor Capital reported no remaining Alaunos Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Sculptor Capital sold 35 Alaunos Therapeutics shares in Q1 2020, an estimated $25K.
  • Sculptor Capital first reported a position in Alaunos Therapeutics in Q3 2016 and held it in 8 quarters.
  • Sculptor Capital's Alaunos Therapeutics position peaked at $985K in Q1 2019.
  • 146 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2020.

Based on Sculptor Capital's 13F filing for Q1 2020, filed 14 May 2020.